Navigation Links
Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
Date:10/18/2011

INDIANAPOLIS, Ind., Oct. 18, 2011 /PRNewswire/ -- Sentry BioPharma Services, a provider of global biopharmaceutical cGMP storage, supply chain management, prescription drug distribution and clinical packaging services, announced today that they have signed a five-year contract with the General Service Administration for inclusion on the Federal Supply Schedule, Logistics Worldwide (LogWorld). Inclusion on this schedule will help Sentry BioPharma secure no bid contracts with many federal government agencies for the provision of temperature-controlled storage and distribution of vaccines and pharmaceutical products.

(Logo: http://photos.prnewswire.com/prnh/20111018/DE87636LOGO)

When asked about the significance of this contract, Ms. Jennifer Marcum, Sentry's CEO, stated that "earning a GSA Contract is not only a testament to Sentry BioPharma's expertise as a biopharmaceutical warehousing and logistics provider and its ability to expeditiously implement key projects.  It is also a validation of our international services, as the application process includes an extensive review of Sentry's prior experience with temperature-controlled vaccine and pharmaceutical storage and logistics, as well as a survey of our clients' satisfaction with our company." Marcum further elaborated by stating that "Sentry's biopharmaceutical storage and drug distribution services are perfectly designed and constructed to support any government agency's needs for the cGMP storage, labeling, kitting and distribution of temperature-sensitive pharmaceutical products, including vaccines and regulated medications." Finally, Marcum stressed that "by investing the resources to complete the GSA contracting process, Sentry expects to gain efficiencies when contracting with federal agencies like Department of Defense (DOD), the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs (VA)."  Additional information regarding Sentry's GSA Contract can be found at GSA eLibrary.

About Sentry BioPharma Services

Sentry BioPharma Services maintains cGMP temperature-controlled storage for vaccine and other biopharmaceutical product, FDA labeling capability, drug distribution licenses and an active Foreign Trade Zone status to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the cGMP warehousing, packaging, cold chain logistics and contract service needs of pharmaceutical and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in pharmaceutical cold chain storage and logistics, quality assurance, biopharmaceutical packaging and kitting development. Sentry also offers strategic solutions for global transportation and logistics, as well as end-to-end import and export management.

The company's validated processes and inventory tracking systems are FDA compliant, adhere to current Good Manufacturing Practices (cGMPs) and comply with stringent standard operating procedures (SOPs) outlined in Sentry's Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Boards of Pharmacy®. The company is privately held and strategically headquartered in Indianapolis, Indiana.

Media Contact:
Ms. April L. Lentz
Sentry BioPharma Services, Inc.
Phone: (866) 757-7400 ext. 107
Email: info@sentrybps.com
Website: www.sentrybps.com


'/>"/>
SOURCE Sentry BioPharma Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
2. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
3. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
4. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
5. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
6. Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research
7. Research Demonstrates Possible Michigan Job Losses from Sectors Supported by Biopharmaceutical Companies
8. Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies
9. Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies
10. CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001
11. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):